Impact of HIV Infection and HAART on Serum Lipids in Men
CONTEXT Alterations in serum lipid values have been widely reported among persons infected with human immunodeficiency virus (HIV) type 1 treated with highly active antiretroviral therapy (HAART), but no data have yet been reported on changes from preseroconversion lipid values. OBJECTIVE To describ...
Gespeichert in:
Veröffentlicht in: | JAMA : the journal of the American Medical Association 2003-06, Vol.289 (22), p.2978-2982 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2982 |
---|---|
container_issue | 22 |
container_start_page | 2978 |
container_title | JAMA : the journal of the American Medical Association |
container_volume | 289 |
creator | Riddler, Sharon A Smit, Ellen Cole, Stephen R Li, Rui Chmiel, Joan S Dobs, Adrian Palella, Frank Visscher, Barbara Evans, Rhobert Kingsley, Lawrence A |
description | CONTEXT Alterations in serum lipid values have been widely reported among persons
infected with human immunodeficiency virus (HIV) type 1 treated with highly
active antiretroviral therapy (HAART), but no data have yet been reported
on changes from preseroconversion lipid values. OBJECTIVE To describe changes in serum cholesterol levels associated with HIV
infection and antiretroviral medication exposure, and 1-time assessment of
triglyceride levels post-HAART initiation. DESIGN, SETTING, AND PARTICIPANTS The Multicenter AIDS Cohort Study, a prospective study in which homosexual
and bisexual men were enrolled and from which 50 of 517 HIV seroconverters
were drawn for the analysis herein, who later initiated HAART, involving measurements
of stored serum samples obtained between 1984 and 2002. MAIN OUTCOME MEASURES Changes in levels of total cholesterol (TC), high-density lipoprotein
cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) at 6
time points during an average of 12 years; 1-time assessment of triglyceride
levels from the third post-HAART clinic visit. RESULTS Among the 50 men, notable declines in mean serum TC (–30 mg/dL
[−0.78 mmol/L]), HDL-C (–12 mg/dL [−0.31 mmol/L]), and LDL-C
values (–22 mg/dL [−0.57 mmol/L]) were observed after HIV infection.
Following HAART initiation, there were large increases in mean TC and LDL-C
values (50 and 21 mg/dL [1.30 and 0.54 mmol/L], respectively); however, the
mean changes from the preseroconversion values were 20 mg/dL (0.52 mmol/L)
(95% confidence interval [CI], –1 to 41) and –1 mg/dL (−0.03
mmol/L) (95% CI, –25 to 22), respectively. Mean HDL-C remained below
baseline levels throughout follow-up. The median value (interquartile range)
of triglycerides was 225 mg/dL (2.54 mmol/L) (147-331 mg/dL). CONCLUSIONS Before treatment, HIV infection results in substantial decreases in
serum TC, HDL-C, and LDL-C levels. Subsequent HAART initiation is associated
with increases in TC and LDL-C but little change in HDL-C. Increases in TC
and LDL-C observed after about 3 years of HAART possibly represent a return
to preinfection serum lipid levels after accounting for expected age-related
changes. |
doi_str_mv | 10.1001/jama.289.22.2978 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_73358563</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>196714</ama_id><sourcerecordid>19234356</sourcerecordid><originalsourceid>FETCH-LOGICAL-a468t-acf3fbe35610565184cb90ab55847632bcbd4697b1ba6b8ef12b7d500abb4bcb3</originalsourceid><addsrcrecordid>eNqF0c1LwzAUAPAgipvTu14kCHprzffHcQx1hYmg02tJ2hQ62nQ27cH_3sgmAy_m8gjvx-N9AHCJUYoRwvcb05qUKJ0SkhIt1RGYYk5VQrlWx2CKkFaJZIpNwFkIGxQfpvIUTDCRWjMkpkBl7dYUA-wquMw-YOYrVwx156HxJVzO569rGD9vrh9buKq3dRlg7eGz8-fgpDJNcBf7OAPvjw_rxTJZvTxli_kqMUyoITFFRSvrKBcYccGxYoXVyFjOFZOCElvYkgktLbZGWOUqTKwsOYrEspikM3C3q7vtu8_RhSFv61C4pjHedWPIJaVccUH_hVgTymIfEd78gZtu7H0cIicY_6xOoIiu92i0rSvzbV-3pv_KfzcXwe0emFCYpuqNL-pwcExJrTCJ7mrn4qkOWS0kZvQbRmKCIQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>211359860</pqid></control><display><type>article</type><title>Impact of HIV Infection and HAART on Serum Lipids in Men</title><source>MEDLINE</source><source>American Medical Association Journals</source><creator>Riddler, Sharon A ; Smit, Ellen ; Cole, Stephen R ; Li, Rui ; Chmiel, Joan S ; Dobs, Adrian ; Palella, Frank ; Visscher, Barbara ; Evans, Rhobert ; Kingsley, Lawrence A</creator><creatorcontrib>Riddler, Sharon A ; Smit, Ellen ; Cole, Stephen R ; Li, Rui ; Chmiel, Joan S ; Dobs, Adrian ; Palella, Frank ; Visscher, Barbara ; Evans, Rhobert ; Kingsley, Lawrence A</creatorcontrib><description>CONTEXT Alterations in serum lipid values have been widely reported among persons
infected with human immunodeficiency virus (HIV) type 1 treated with highly
active antiretroviral therapy (HAART), but no data have yet been reported
on changes from preseroconversion lipid values. OBJECTIVE To describe changes in serum cholesterol levels associated with HIV
infection and antiretroviral medication exposure, and 1-time assessment of
triglyceride levels post-HAART initiation. DESIGN, SETTING, AND PARTICIPANTS The Multicenter AIDS Cohort Study, a prospective study in which homosexual
and bisexual men were enrolled and from which 50 of 517 HIV seroconverters
were drawn for the analysis herein, who later initiated HAART, involving measurements
of stored serum samples obtained between 1984 and 2002. MAIN OUTCOME MEASURES Changes in levels of total cholesterol (TC), high-density lipoprotein
cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) at 6
time points during an average of 12 years; 1-time assessment of triglyceride
levels from the third post-HAART clinic visit. RESULTS Among the 50 men, notable declines in mean serum TC (–30 mg/dL
[−0.78 mmol/L]), HDL-C (–12 mg/dL [−0.31 mmol/L]), and LDL-C
values (–22 mg/dL [−0.57 mmol/L]) were observed after HIV infection.
Following HAART initiation, there were large increases in mean TC and LDL-C
values (50 and 21 mg/dL [1.30 and 0.54 mmol/L], respectively); however, the
mean changes from the preseroconversion values were 20 mg/dL (0.52 mmol/L)
(95% confidence interval [CI], –1 to 41) and –1 mg/dL (−0.03
mmol/L) (95% CI, –25 to 22), respectively. Mean HDL-C remained below
baseline levels throughout follow-up. The median value (interquartile range)
of triglycerides was 225 mg/dL (2.54 mmol/L) (147-331 mg/dL). CONCLUSIONS Before treatment, HIV infection results in substantial decreases in
serum TC, HDL-C, and LDL-C levels. Subsequent HAART initiation is associated
with increases in TC and LDL-C but little change in HDL-C. Increases in TC
and LDL-C observed after about 3 years of HAART possibly represent a return
to preinfection serum lipid levels after accounting for expected age-related
changes.</description><identifier>ISSN: 0098-7484</identifier><identifier>EISSN: 1538-3598</identifier><identifier>DOI: 10.1001/jama.289.22.2978</identifier><identifier>PMID: 12799406</identifier><identifier>CODEN: JAMAAP</identifier><language>eng</language><publisher>Chicago, IL: American Medical Association</publisher><subject>Adult ; Anti-HIV Agents - pharmacology ; Anti-HIV Agents - therapeutic use ; Antiretroviral Therapy, Highly Active ; Biological and medical sciences ; cholesterol ; Cholesterol, HDL - blood ; Cholesterol, LDL - blood ; Drug toxicity and drugs side effects treatment ; highly active antiretroviral therapy ; HIV ; HIV Infections - blood ; HIV Infections - drug therapy ; HIV Seropositivity - blood ; HIV Seropositivity - drug therapy ; HIV-1 ; Human immunodeficiency virus ; Humans ; Infections ; Lipids ; Lipids - blood ; Male ; Medical sciences ; Men ; Miscellaneous (drug allergy, mutagens, teratogens...) ; Pharmacology. Drug treatments ; Regression Analysis ; triglycerides ; Triglycerides - blood</subject><ispartof>JAMA : the journal of the American Medical Association, 2003-06, Vol.289 (22), p.2978-2982</ispartof><rights>2003 INIST-CNRS</rights><rights>Copyright American Medical Association Jun 11, 2003</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a468t-acf3fbe35610565184cb90ab55847632bcbd4697b1ba6b8ef12b7d500abb4bcb3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://jamanetwork.com/journals/jama/articlepdf/10.1001/jama.289.22.2978$$EPDF$$P50$$Gama$$H</linktopdf><linktohtml>$$Uhttps://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.289.22.2978$$EHTML$$P50$$Gama$$H</linktohtml><link.rule.ids>64,314,780,784,3331,27915,27916,76250,76253</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14879812$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12799406$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Riddler, Sharon A</creatorcontrib><creatorcontrib>Smit, Ellen</creatorcontrib><creatorcontrib>Cole, Stephen R</creatorcontrib><creatorcontrib>Li, Rui</creatorcontrib><creatorcontrib>Chmiel, Joan S</creatorcontrib><creatorcontrib>Dobs, Adrian</creatorcontrib><creatorcontrib>Palella, Frank</creatorcontrib><creatorcontrib>Visscher, Barbara</creatorcontrib><creatorcontrib>Evans, Rhobert</creatorcontrib><creatorcontrib>Kingsley, Lawrence A</creatorcontrib><title>Impact of HIV Infection and HAART on Serum Lipids in Men</title><title>JAMA : the journal of the American Medical Association</title><addtitle>JAMA</addtitle><description>CONTEXT Alterations in serum lipid values have been widely reported among persons
infected with human immunodeficiency virus (HIV) type 1 treated with highly
active antiretroviral therapy (HAART), but no data have yet been reported
on changes from preseroconversion lipid values. OBJECTIVE To describe changes in serum cholesterol levels associated with HIV
infection and antiretroviral medication exposure, and 1-time assessment of
triglyceride levels post-HAART initiation. DESIGN, SETTING, AND PARTICIPANTS The Multicenter AIDS Cohort Study, a prospective study in which homosexual
and bisexual men were enrolled and from which 50 of 517 HIV seroconverters
were drawn for the analysis herein, who later initiated HAART, involving measurements
of stored serum samples obtained between 1984 and 2002. MAIN OUTCOME MEASURES Changes in levels of total cholesterol (TC), high-density lipoprotein
cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) at 6
time points during an average of 12 years; 1-time assessment of triglyceride
levels from the third post-HAART clinic visit. RESULTS Among the 50 men, notable declines in mean serum TC (–30 mg/dL
[−0.78 mmol/L]), HDL-C (–12 mg/dL [−0.31 mmol/L]), and LDL-C
values (–22 mg/dL [−0.57 mmol/L]) were observed after HIV infection.
Following HAART initiation, there were large increases in mean TC and LDL-C
values (50 and 21 mg/dL [1.30 and 0.54 mmol/L], respectively); however, the
mean changes from the preseroconversion values were 20 mg/dL (0.52 mmol/L)
(95% confidence interval [CI], –1 to 41) and –1 mg/dL (−0.03
mmol/L) (95% CI, –25 to 22), respectively. Mean HDL-C remained below
baseline levels throughout follow-up. The median value (interquartile range)
of triglycerides was 225 mg/dL (2.54 mmol/L) (147-331 mg/dL). CONCLUSIONS Before treatment, HIV infection results in substantial decreases in
serum TC, HDL-C, and LDL-C levels. Subsequent HAART initiation is associated
with increases in TC and LDL-C but little change in HDL-C. Increases in TC
and LDL-C observed after about 3 years of HAART possibly represent a return
to preinfection serum lipid levels after accounting for expected age-related
changes.</description><subject>Adult</subject><subject>Anti-HIV Agents - pharmacology</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>Antiretroviral Therapy, Highly Active</subject><subject>Biological and medical sciences</subject><subject>cholesterol</subject><subject>Cholesterol, HDL - blood</subject><subject>Cholesterol, LDL - blood</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>highly active antiretroviral therapy</subject><subject>HIV</subject><subject>HIV Infections - blood</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Seropositivity - blood</subject><subject>HIV Seropositivity - drug therapy</subject><subject>HIV-1</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Infections</subject><subject>Lipids</subject><subject>Lipids - blood</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Men</subject><subject>Miscellaneous (drug allergy, mutagens, teratogens...)</subject><subject>Pharmacology. Drug treatments</subject><subject>Regression Analysis</subject><subject>triglycerides</subject><subject>Triglycerides - blood</subject><issn>0098-7484</issn><issn>1538-3598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0c1LwzAUAPAgipvTu14kCHprzffHcQx1hYmg02tJ2hQ62nQ27cH_3sgmAy_m8gjvx-N9AHCJUYoRwvcb05qUKJ0SkhIt1RGYYk5VQrlWx2CKkFaJZIpNwFkIGxQfpvIUTDCRWjMkpkBl7dYUA-wquMw-YOYrVwx156HxJVzO569rGD9vrh9buKq3dRlg7eGz8-fgpDJNcBf7OAPvjw_rxTJZvTxli_kqMUyoITFFRSvrKBcYccGxYoXVyFjOFZOCElvYkgktLbZGWOUqTKwsOYrEspikM3C3q7vtu8_RhSFv61C4pjHedWPIJaVccUH_hVgTymIfEd78gZtu7H0cIicY_6xOoIiu92i0rSvzbV-3pv_KfzcXwe0emFCYpuqNL-pwcExJrTCJ7mrn4qkOWS0kZvQbRmKCIQ</recordid><startdate>20030611</startdate><enddate>20030611</enddate><creator>Riddler, Sharon A</creator><creator>Smit, Ellen</creator><creator>Cole, Stephen R</creator><creator>Li, Rui</creator><creator>Chmiel, Joan S</creator><creator>Dobs, Adrian</creator><creator>Palella, Frank</creator><creator>Visscher, Barbara</creator><creator>Evans, Rhobert</creator><creator>Kingsley, Lawrence A</creator><general>American Medical Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QL</scope><scope>7QP</scope><scope>7TK</scope><scope>7TS</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20030611</creationdate><title>Impact of HIV Infection and HAART on Serum Lipids in Men</title><author>Riddler, Sharon A ; Smit, Ellen ; Cole, Stephen R ; Li, Rui ; Chmiel, Joan S ; Dobs, Adrian ; Palella, Frank ; Visscher, Barbara ; Evans, Rhobert ; Kingsley, Lawrence A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a468t-acf3fbe35610565184cb90ab55847632bcbd4697b1ba6b8ef12b7d500abb4bcb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adult</topic><topic>Anti-HIV Agents - pharmacology</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>Antiretroviral Therapy, Highly Active</topic><topic>Biological and medical sciences</topic><topic>cholesterol</topic><topic>Cholesterol, HDL - blood</topic><topic>Cholesterol, LDL - blood</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>highly active antiretroviral therapy</topic><topic>HIV</topic><topic>HIV Infections - blood</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Seropositivity - blood</topic><topic>HIV Seropositivity - drug therapy</topic><topic>HIV-1</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Infections</topic><topic>Lipids</topic><topic>Lipids - blood</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Men</topic><topic>Miscellaneous (drug allergy, mutagens, teratogens...)</topic><topic>Pharmacology. Drug treatments</topic><topic>Regression Analysis</topic><topic>triglycerides</topic><topic>Triglycerides - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Riddler, Sharon A</creatorcontrib><creatorcontrib>Smit, Ellen</creatorcontrib><creatorcontrib>Cole, Stephen R</creatorcontrib><creatorcontrib>Li, Rui</creatorcontrib><creatorcontrib>Chmiel, Joan S</creatorcontrib><creatorcontrib>Dobs, Adrian</creatorcontrib><creatorcontrib>Palella, Frank</creatorcontrib><creatorcontrib>Visscher, Barbara</creatorcontrib><creatorcontrib>Evans, Rhobert</creatorcontrib><creatorcontrib>Kingsley, Lawrence A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>JAMA : the journal of the American Medical Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Riddler, Sharon A</au><au>Smit, Ellen</au><au>Cole, Stephen R</au><au>Li, Rui</au><au>Chmiel, Joan S</au><au>Dobs, Adrian</au><au>Palella, Frank</au><au>Visscher, Barbara</au><au>Evans, Rhobert</au><au>Kingsley, Lawrence A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of HIV Infection and HAART on Serum Lipids in Men</atitle><jtitle>JAMA : the journal of the American Medical Association</jtitle><addtitle>JAMA</addtitle><date>2003-06-11</date><risdate>2003</risdate><volume>289</volume><issue>22</issue><spage>2978</spage><epage>2982</epage><pages>2978-2982</pages><issn>0098-7484</issn><eissn>1538-3598</eissn><coden>JAMAAP</coden><abstract>CONTEXT Alterations in serum lipid values have been widely reported among persons
infected with human immunodeficiency virus (HIV) type 1 treated with highly
active antiretroviral therapy (HAART), but no data have yet been reported
on changes from preseroconversion lipid values. OBJECTIVE To describe changes in serum cholesterol levels associated with HIV
infection and antiretroviral medication exposure, and 1-time assessment of
triglyceride levels post-HAART initiation. DESIGN, SETTING, AND PARTICIPANTS The Multicenter AIDS Cohort Study, a prospective study in which homosexual
and bisexual men were enrolled and from which 50 of 517 HIV seroconverters
were drawn for the analysis herein, who later initiated HAART, involving measurements
of stored serum samples obtained between 1984 and 2002. MAIN OUTCOME MEASURES Changes in levels of total cholesterol (TC), high-density lipoprotein
cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) at 6
time points during an average of 12 years; 1-time assessment of triglyceride
levels from the third post-HAART clinic visit. RESULTS Among the 50 men, notable declines in mean serum TC (–30 mg/dL
[−0.78 mmol/L]), HDL-C (–12 mg/dL [−0.31 mmol/L]), and LDL-C
values (–22 mg/dL [−0.57 mmol/L]) were observed after HIV infection.
Following HAART initiation, there were large increases in mean TC and LDL-C
values (50 and 21 mg/dL [1.30 and 0.54 mmol/L], respectively); however, the
mean changes from the preseroconversion values were 20 mg/dL (0.52 mmol/L)
(95% confidence interval [CI], –1 to 41) and –1 mg/dL (−0.03
mmol/L) (95% CI, –25 to 22), respectively. Mean HDL-C remained below
baseline levels throughout follow-up. The median value (interquartile range)
of triglycerides was 225 mg/dL (2.54 mmol/L) (147-331 mg/dL). CONCLUSIONS Before treatment, HIV infection results in substantial decreases in
serum TC, HDL-C, and LDL-C levels. Subsequent HAART initiation is associated
with increases in TC and LDL-C but little change in HDL-C. Increases in TC
and LDL-C observed after about 3 years of HAART possibly represent a return
to preinfection serum lipid levels after accounting for expected age-related
changes.</abstract><cop>Chicago, IL</cop><pub>American Medical Association</pub><pmid>12799406</pmid><doi>10.1001/jama.289.22.2978</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0098-7484 |
ispartof | JAMA : the journal of the American Medical Association, 2003-06, Vol.289 (22), p.2978-2982 |
issn | 0098-7484 1538-3598 |
language | eng |
recordid | cdi_proquest_miscellaneous_73358563 |
source | MEDLINE; American Medical Association Journals |
subjects | Adult Anti-HIV Agents - pharmacology Anti-HIV Agents - therapeutic use Antiretroviral Therapy, Highly Active Biological and medical sciences cholesterol Cholesterol, HDL - blood Cholesterol, LDL - blood Drug toxicity and drugs side effects treatment highly active antiretroviral therapy HIV HIV Infections - blood HIV Infections - drug therapy HIV Seropositivity - blood HIV Seropositivity - drug therapy HIV-1 Human immunodeficiency virus Humans Infections Lipids Lipids - blood Male Medical sciences Men Miscellaneous (drug allergy, mutagens, teratogens...) Pharmacology. Drug treatments Regression Analysis triglycerides Triglycerides - blood |
title | Impact of HIV Infection and HAART on Serum Lipids in Men |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T18%3A55%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20HIV%20Infection%20and%20HAART%20on%20Serum%20Lipids%20in%20Men&rft.jtitle=JAMA%20:%20the%20journal%20of%20the%20American%20Medical%20Association&rft.au=Riddler,%20Sharon%20A&rft.date=2003-06-11&rft.volume=289&rft.issue=22&rft.spage=2978&rft.epage=2982&rft.pages=2978-2982&rft.issn=0098-7484&rft.eissn=1538-3598&rft.coden=JAMAAP&rft_id=info:doi/10.1001/jama.289.22.2978&rft_dat=%3Cproquest_pubme%3E19234356%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=211359860&rft_id=info:pmid/12799406&rft_ama_id=196714&rfr_iscdi=true |